Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study

Table 6 Frequency of attacks with or without prophylaxis / IRT in 2012

				Number of Angioedema attacks
				no attacks	≥1/week^a	≥1/month ≤ 1/week^b	≥1/year ≤ 1/month^c	Total n of AE
Women and men			104	26	10	30	38	1770
Women	All		57	12	8	22	15	1290
	prophylaxis	None	38	5	7	18	8	835
		Danazol	13	6	1	2	4	143
		TA	6	1	0	2	3	48
	IRT	C1-INH	7	0	2	4	1	264
men	All		47	14	2	8	23	480
	prophylaxis	None	30	9	1	5	15	216
		Danazol	13	4	0	2	7	64
		TA	4	1	1	1	1	78
	IRT	C1-INH	2	0	0	1	1	122

^afrequent number of attacks; ^bintermediate number of attacks; ^crare number of attacks
n number, AE Angioedema
no attacks: asymptomatic for the year 2012

ISSN: 1750-1172